Press Releases concerning clinical trial results are intended to inform interested parties of the advancements of laser technology in process, not to imply new indications for use. Erchonia supports only those indications for use, cleared by the FDA via 510(k).
Model Wins a Trip to Florida, $5,000 cash and Stars in Zerona’s 2012 Marketing Campaign
Erchonia’s Body Contouring Clinical Trial Published in Lasers in Surgery and Medicine
McKinney, TX – December 16, 2009 – Erchonia, the leading developer of non-invasive, low level laser healthcare applications, announces today the results of its body contouring clinical trial are being published in Lasers in Surgery and Medicine’s January issue.
Top Rated Daytime Talk Show Features a Dramatic Zerona Makeover
Erchonia’s Low Level Laser Therapy Improves Breast Augmentation Procedures
McKinney, Texas, August 1, 2007 – Erchonia Corporation announced today the results of a double-blind randomized, placebo-controlled clinical study in which low level laser therapy was shown to significantly improve the post-surgical pain experienced after breast augmentation procedures.